No Data
No Data
Needham Initiates Neumora Therapeutics(NMRA.US) With Buy Rating, Announces Target Price $23
Needham analyst Ami Fadia initiates coverage on $Neumora Therapeutics(NMRA.US)$ with a buy rating, and sets the target price at $23.According to TipRanks data, the analyst has a success rate of 47.4%
Express News | Neumora Therapeutics Inc : Needham Initiates Coverage With Buy Rating; Target Price $23
Mizuho Starts Neumora at Outperform, Bullish on Lead Drug's Prospects
Mizuho Securities Initiates Neumora Therapeutics(NMRA.US) With Buy Rating, Announces Target Price $20
Mizuho Securities analyst Graig Suvannavejh initiates coverage on $Neumora Therapeutics(NMRA.US)$ with a buy rating, and sets the target price at $20.According to TipRanks data, the analyst has a succ
Neumora Therapeutics Price Target Announced at $20.00/Share by Mizuho
Neumora Therapeutics Initiated at Outperform by Mizuho
No Data